Tri Locum Partners LP Protara Therapeutics, Inc. Call Options Transaction History
Tri Locum Partners LP
- $278 Million
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TARA
# of Institutions
82Shares Held
28MCall Options Held
37.2KPut Options Held
65.1K-
Janus Henderson Group PLC London, X04.1MShares$20 Million0.01% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA2.14MShares$10.4 Million11.14% of portfolio
-
Blackstone Inc New York, NY1.91MShares$9.32 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.8MShares$8.79 Million0.0% of portfolio
-
Acorn Capital Advisors, LLC New York, NY1.75MShares$8.55 Million3.47% of portfolio
About Protara Therapeutics, Inc.
- Ticker TARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,267,400
- Market Cap $55M
- Description
- Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the identifying and advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy for the treatment of lymphatic malformations. It also develops intravenous choline chlorid...